Abstract
The removal of urokinase from the market has created a dilemma for interventionists and vascular surgeons treating patients with acute limb threatening ischemia due to arterial thrombosis or embolization. Reteplase is a newer, fibrin-specific thrombolytic agent with properties that make it an attractive alternative to urokinase. We report two cases of successful treatment of acute, limb threatening ischemia with intra-arterial Reteplase therapy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 757-762 |
| Number of pages | 6 |
| Journal | Journal of Invasive Cardiology |
| Volume | 11 |
| Issue number | 12 |
| State | Published - 1999 |
| Externally published | Yes |
Keywords
- Peripheral vascular disease
- Thrombolysis
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine